Abstract
Human bone marrow mesenchymal stromal cells (hBM-MSCs) are a promising tools for cell therapy. However, the poor viability of the transplanted cells is a major limiting factor. Human erythropoietin (hEPO) has been extensively studied in non-hematopoietic tissues for its neurotrophic, anti-oxidant, antiapoptotic, and anti-inflammatory effects. In this study, we evaluate whether transduction of the hEPO gene into MSCs provides protection and affects their migration. hBM-MSCs transduced with the hEPO gene (EPO-MSCs) stably secreted high levels of hEPO (10 IU/ml) with no alteration of their mesenchymal phenotype. MSCs were also treated with 10 IU rhEPO, an amount similar to what was secreted by EPO-MSCs, to generate 10U-MSCs. Protection against H2O2-induced oxidative stress and staurosporine-induced apoptosis was registered for both EPO-MSCs and 10U-MSCs, but the protective effects were higher for the EPO-MSCs than for the 10U-MSCs. EPO-MSCs had significantly higher migration rates compared to MSCs and 10U-MSCs. We confirmed that the intracellular signaling of ERK1/2 was higher in the EPO-MSCs than 10U-MSCs. This data demonstrates that the endogenous expression of EPO may efficiently initiate the ERK1/2 signaling pathway, resulting in synergistic effects on the production of neurotrophic factors. Thus, EPO-MSCs are a good candidate for cell therapy in ischemic and neurodegenerative diseases.
Original language | English |
---|---|
Pages (from-to) | 577-584 |
Number of pages | 8 |
Journal | Molecular Biology |
Volume | 44 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2010 |
Bibliographical note
Funding Information:This work was supported by National Research Foundation (NRF) grant funded by the Korea govern ment (MEST) (NRF 2006 2004670) and by Basic Science Research Program though the National Research Foundation of Korea (NRF) funded by the Ministry of Education. Science and Technology (NRF 2008 313 E00480).
All Science Journal Classification (ASJC) codes
- Biophysics
- Structural Biology